Lipid bilayer in genetic hypertension.
Membrane microviscosity, phospholipid composition, and turnover were measured in cultured vascular smooth muscle cells isolated from mesenteric arteries of stroke-prone spontaneously hypertensive and age-matched, normotensive Wistar-Kyoto rats. Membrane microviscosity, measured with fluorescence polarization, revealed greater microviscosity (lower fluidity) of the membranes isolated from smooth muscle cells from hypertensive as compared with those isolated from normotensive rats (p less than 0.01). Preincubation of membranes from hypertensive rats with 5 mM calcium reduced membrane microviscosity in "core" and in "surface" regions of the bilayer toward values observed in Wistar-Kyoto rats. Phospholipid composition did not differ between intact aortas and cultured mesenteric cells or between those tissues obtained from normotensive and from hypertensive rats. The total lipid-associated radioactivity was significantly lower in cells from stroke-prone spontaneously hypertensive rats than in those from Wistar-Kyoto controls (p less than 0.01). Phosphatidylcholine incorporated 70% and phosphatidylinositol 16% of total lipid-associated radioactivity, with no difference between cells from hypertensive and normotensive animals. Turnover of phosphatidylethanolamine was greater in cells from Wistar-Kyoto rats (p = 0.02), whereas turnover of phosphatidylserine was greater in cells from stroke-prone spontaneously hypertensive rats (p = 0.04). The greater microviscosity of the lipid bilayer in hypertension is a generalized defect of the matrix in which the transport proteins function. We hypothesize that this defect is responsible for the multiple abnormalities of membrane transport systems that have been described in genetic hypertension.
Dominiczak
A F
AF
Department of Physiology, University of Michigan, Ann Arbor.
Lazar
D F
DF
Das
A K
AK
Bohr
D F
DF
D000818:Animals; D001011:Aorta; D001792:Blood Platelets / Q000737:chemistry; D002118:Calcium / Q000494:pharmacology; D002462:Cell Membrane / Q000737:chemistry* / Q000648:ultrastructure; D002478:Cells, Cultured; D006973:Hypertension / Q000235:genetics* / Q000473:pathology; D008563:Membrane Lipids / Q000032:analysis* / Q000378:metabolism; D008638:Mesenteric Arteries; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D010712:Phosphatidic Acids / Q000032:analysis; D010713:Phosphatidylcholines / Q000032:analysis; D010714:Phosphatidylethanolamines / Q000032:analysis; D010716:Phosphatidylinositols / Q000032:analysis; D010718:Phosphatidylserines / Q000032:analysis; D011048:Polarography; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013109:Sphingomyelins / Q000032:analysis; D014783:Viscosity / Q000187:drug effects
D008563:Membrane Lipids; D010712:Phosphatidic Acids; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010716:Phosphatidylinositols; D010718:Phosphatidylserines; D013109:Sphingomyelins; D002118:Calcium